Skip to main content

Year: 2023

U.S. SMEs struggle with sustainability more than global peers, find reporting standards complex and costly

Sage research identifies the motivators and roadblocks for American businesses to become more sustainableAlmost half (45%) of U.S. SMEs describe environmental reporting standards and frameworks as too complex Reducing barriers could open up new financial avenues, growth, and employment opportunities for SMEs  Sage is calling for simpler reporting frameworks and tech-forward support for SMEs looking to take actionATLANTA, Nov. 16, 2023 (GLOBE NEWSWIRE) — U.S. small and medium enterprises (SMEs) are grappling to keep up with the jargon and technical expertise of sustainability reporting and standards, according to Sage, the leader in accounting, financial, HR, and payroll technology for small and mid-sized businesses. A global study of 16,423 SMEs launched today shows that a promising number of businesses want to make progress...

Continue reading

Canadian SMBs most likely to struggle with understanding ESG reporting standards

Sage releases research identifying SMB motivators and roadblocks to becoming more sustainableMajority (74%) of Canadian SMBs feel environmental reporting standards and frameworks are too complex Removing barriers will unlock new finance, growth and hiring opportunities for businesses Sage is calling for simpler reporting frameworks and tech-forward support for SMBs looking to take actionTORONTO, Nov. 16, 2023 (GLOBE NEWSWIRE) — Canadian SMBs are grappling to keep up with the jargon and technical expertise of sustainability reporting and standards, according to Sage, the leader in accounting, financial, HR, and payroll technology for small and mid-sized businesses (SMBs). A global study of 16,423 small and medium-sized businesses (SMBs), launched today, shows that a promising number of SMBs want to make progress on their path...

Continue reading

Gabelli Healthcare & WellnessRx Trust Declares Fourth Quarter Distribution of $0.15 Per Share

RYE, N.Y., Nov. 16, 2023 (GLOBE NEWSWIRE) — The Board of Trustees of The Gabelli Healthcare & WellnessRx Trust (NYSE:GRX) (the “Fund”) declared a $0.15 per share cash distribution payable on December 22, 2023 to common shareholders of record on December 15, 2023. The Fund intends to pay a quarterly distribution of an amount determined each quarter by the Board of Trustees. In addition to the quarterly distributions, and in accordance with the minimum distribution requirements of the Internal Revenue Code for regulated investment companies, the Fund may pay an adjusting distribution in December which includes any additional income and net realized capital gains in excess of the quarterly distributions for that year. Each quarter, the Board of Trustees reviews the amount of any potential distribution and the income, realized...

Continue reading

Gabelli Global Small and Mid Cap Value Trust Declares Fourth Quarter Distribution of $0.16 Per Share

RYE, N.Y., Nov. 16, 2023 (GLOBE NEWSWIRE) — The Board of Trustees of The Gabelli Global Small and Mid Cap Value Trust (NYSE:GGZ) (the “Fund”) declared a $0.16 per share cash distribution payable on December 22, 2023 to common shareholders of record on December 15, 2023. The Fund intends to pay a quarterly distribution of an amount determined each quarter by the Board of Trustees. In addition to the quarterly distributions, and in accordance with the minimum distribution requirements of the Internal Revenue Code for regulated investment companies, the Fund may pay an adjusting distribution in December which includes any additional income and net realized capital gains in excess of the quarterly distributions for that year. Each quarter, the Board of Trustees reviews the amount of any potential distribution from the income, realized...

Continue reading

Gabelli Multimedia Trust 10% Distribution Policy Reaffirmed And Declared Fourth Quarter Distribution Of $0.22 Per Share

RYE, N.Y., Nov. 16, 2023 (GLOBE NEWSWIRE) — The Board of Directors of The Gabelli Multimedia Trust Inc. (NYSE:GGT) (the “Fund”) reaffirmed and satisfied its 10% distribution policy by declaring a $0.22 per share cash distribution payable on December 22, 2023 to common stock shareholders of record on December 15, 2023. With this fourth quarter distribution, the total distributions from the Fund for 2023 would equate to $0.88 per share. The Fund intends to pay a minimum annual distribution of 10% of the average net asset value of the Fund within a calendar year or an amount sufficient to satisfy the minimum distribution requirements of the Internal Revenue Code for regulated investment companies. Each quarter, the Board of Directors reviews the amount of any potential distribution from the income, realized capital gain, or capital...

Continue reading

Cheetah Net Supply Chain Services Inc. Executes Letter of Intent to Acquire Edward Transit Express Group Inc.

Transaction Anticipated to Close in Early 2024 CHARLOTTE, N.C., Nov. 16, 2023 (GLOBE NEWSWIRE) — Cheetah Net Supply Chain Services Inc. (“Cheetah” or the “Company”) (Nasdaq CM: CTNT) announced today the signing of a letter of intent with Edward Transit Express Group Inc. (“Edward”), a California-based global inbound non-vessel operating common carrier providing ocean and air transportation services. Edward operates a weekly consolidation service through its worldwide agency network system for loose cargoes and full containers for inbound and outbound shipments. The total purchase price for Edward is $1.5 million, consisting of $300,000 in cash and $1.2 million in Cheetah’s Class A common stock. The completion of the transaction is subject to various conditions, including the favorable completion of due diligence on Edward and the...

Continue reading

Gabelli Dividend & Income Trust Continues Monthly Distributions, Declares Distributions of $0.11 Per Share

RYE, N.Y., Nov. 16, 2023 (GLOBE NEWSWIRE) — The Board of Trustees of The Gabelli Dividend & Income Trust (NYSE:GDV) (the “Fund”) approved the continuation of its policy of paying fixed monthly cash distributions. The Board of Trustees declared cash distributions of $0.11 per share for each of January, February, and March 2024. Distribution Month Record Date Payable Date  Distribution Per Share January January 17, 2024 January 24, 2024  $0.11 February February 14, 2024 February 22, 2024  $0.11 March March 14, 2024 March 21, 2024  $0.11Each quarter, the Board of Trustees reviews the amount of any potential distribution from the income, realized capital gain, or capital available. The Board of Trustees will continue to monitor the Fund’s distribution level, taking into consideration the Fund’s net asset value and...

Continue reading

Mainz Biomed Reports Third Quarter 2023 Financial Results and Provides Corporate Update

ColoAlert® Revenue Increases 102% Year Over Year for the Nine Months Ended September 30, 2023 ColoFuture Study Reported Groundbreaking Results Demonstrating Sensitivity for Colorectal Cancer of 94% with Specificity of 97% and Advanced Adenoma Sensitivity of 80% BERKELEY, Calif. and MAINZ, Germany, Nov. 16, 2023 (GLOBE NEWSWIRE) — Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, announced today its financial results of the third quarter ending September 30, 2023 and provided a corporate update. Key Highlights:ColoAlert® revenues were USD 681,000, representing an increase of 102% compared to the first nine months of 2022. Reported groundbreaking clinical trial results from ColoFuture, an international study evaluating the Company’s...

Continue reading

BioSyent Releases Q3 and YTD 2023 Financial Results

MISSISSAUGA, Ontario, Nov. 16, 2023 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the three months (Q3) and nine months (YTD) ended September 30, 2023. Key highlights include:(CAD) Q3 2023 % Change vs. Q3 2022 YTD 2023 % Change vs. YTD 2022 Trailing Twelve Months (TTM) Sept 30, 2023 % Change vs. TTM Sept 30, 2022Canadian Pharma Sales 7,432,361 17 % 21,565,801 14 % 28,854,824 13 %International Pharma Sales 992,997 100 % 992,997 76 % 1,110,788 26 %Total Company Sales 8,871,122 31 % 23,316,616 14 % 30,778,546 11 %EBITDA1 2,899,612 49 % 6,276,177 7 % 7,844,209 -8 %Net Income After Taxes (NIAT) 2,350,900 62 % 5,009,336 18 % 6,208,852 1 %Fully Diluted EPS 0.20 67 % 0.41 21 % 0.50 2 %                   Return on Equity for the Trailing Twelve Months...

Continue reading

Brady Corporation Reports Fiscal 2024 First Quarter Results

Sales for the quarter increased 2.9 percent. Organic sales increased 2.7 percent. Gross profit margin increased to 51.7 percent in the first quarter of fiscal 2024 compared to 48.1 percent in the first quarter of fiscal 2023. Diluted EPS increased 22.8 percent to $0.97 in the first quarter of fiscal 2024 compared to $0.79 in the same quarter of the prior year. Diluted EPS Excluding Certain Items* increased 19.0 percent to $1.00 in the first quarter of fiscal 2024 compared to $0.84 in the same quarter of the prior year. During the quarter ended October 31, 2023, we returned $25.5 million to our shareholders in the form of dividends and share repurchases.MILWAUKEE, Nov. 16, 2023 (GLOBE NEWSWIRE) — Brady Corporation (NYSE: BRC) (“Brady” or “Company”), a world leader in identification solutions, today reported its financial results...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.